Eslicarbazepine Acetate
These highlights do not include all the information needed to use ESLICARBAZEPINE ACETATE TABLETS safely and effectively. See full prescribing information for ESLICARBAZEPINE ACETATE TABLETS. ESLICARBAZEPINE ACETATE tablets, for oral use Initial U.S. Approval: 2013
999b341f-fe13-4dd9-bb95-9b0d6a817c4c
HUMAN PRESCRIPTION DRUG LABEL
Apr 3, 2025
Lupin Pharmaceuticals, Inc.
DUNS: 089153071
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Eslicarbazepine Acetate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
Eslicarbazepine Acetate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
Eslicarbazepine Acetate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
Eslicarbazepine Acetate
Product Details
FDA regulatory identification and product classification information